Skip to content
  • Sunday, 26 July 2026
  • 4:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Combination Therapy Targets Cellular Differentiation Blocks to Provide New Treatment Pathway for Acute Myelogenous Leukemia
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Targets Cellular Differentiation Blocks to Provide New Treatment Pathway for Acute Myelogenous Leukemia

Dwi Wanna May 17, 2026 0

In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy aimed at…

Read More
Environmental & Analytical Chemistry

Science News, founded in 1921, continues its mission to provide accurate information on scientific advancements.

Abdurrohim Arsyad Apr 17, 2026 0

The enduring legacy of Science News, established in 1921, is rooted in its unwavering commitment to delivering accurate, accessible, and…

Read More
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Ancient DNA Segregation System Repurposed to Sculpt Cell Shape in Pivotal Photosynthetic BacteriaBeyond PD-1: The drugs reshaping cancer treatment at ASCO 2026The Rise of AI Agent Skill Marketplaces: A New Frontier in Autonomous AI Development and Deployment.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ